Taken together, these results suggest IGF2 can promote tumor growth, in part through direct or indirect myeloid cell polarization, which is supported by IGF2 receptor expression in myeloid cells in the TME and high IGF2 expression in a subset of human GBM tumors. The gene discussed is IGF2; the disease is neoplasm.